MiMedx Group (NASDAQ: MDXG) reported Q2 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $45.7 million versus the consensus estimate of $45.03 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.